Advertisement

Morbus Crohn

  • J. Schmidt
  • C. Herfarth

Zusammenfassung

Im Jahre 1932 beschrieben Crohn, Ginzburg und Oppenheimer „eine Erkrankung des terminalen Ileums, die überwiegend junge Erwachsene betrifft und durch eine subakute oder chronische nekrotisierende und vernarbende Entzündung“ gekennzeichnet ist. Die chronische transmurale Entzündung führte in vielen Fällen zu Stenosierungen mit konsekutiver Passageproblematik und Fistelbildung. Dem Terminus Ileitis regionalis folgte durch die zunehmende Erkenntnis der Möglichkeit des Befalls des gesamten Gastrointestinaltraktes die Bezeichnung Enteritis regionalis. Heute ist der Morbus Crohn der international anerkannte Begriff für diese Krankheitsentität, die häufig mit extraintestinalen Symptomen einhergehen kann.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Alexander-Williams J (1982) „Strictureplasty” beim M. Crohn. Chirurg 53:799–801Google Scholar
  2. Anseline P (1995) Crohn’s disease in the Hunter valley region of Australia. Aust N Z J Surg 65:564–569PubMedCrossRefGoogle Scholar
  3. Bauer JJ, Harris MT, Grumbach NW et al. (1995) Laparoscopic assisted intestinal resection for Crohn’s disease. Dis Colon Rectum 38:712–715PubMedCrossRefGoogle Scholar
  4. Best WR, Becktel JM, Singleton JW (1979) Rederived values of eight coefficients of the Crohn’s disease activity index. Gastroenterology 77:843–846PubMedGoogle Scholar
  5. Best WR, Becktel JM, Singleton JW, Kern F Jr (1976) Development of Crohn’s disease activity index. Gastroenterology 70:439PubMedGoogle Scholar
  6. Binder V, Both H, Hansen PK, Hendriksen C, Kreiner S, Torp-Pedersen K (1982) Incidence and prevalence of ulcerative colitis and Crohn’s disease in the county of Copenhagen 1962–1978. Gastroenterology 83:563–568PubMedGoogle Scholar
  7. Borody T, Pearce L, Bampton PA, Leis S (1998) Treatment of severe Crohn’s disease using Rifabutin-Macrolide-Clofazimi-ne combination: Interim Report. Gastroenterology 114: A938CrossRefGoogle Scholar
  8. Broe PJ, Bayless TM, Cameron JL (1982) Crohn’s disease: Are enteroenteral fistulas an indication for surgery? Surgery 91:249–253PubMedGoogle Scholar
  9. Chardavayne R, Flint GW, Pollack S et al. (1986) Factors affecting recurrence following resection for Crohn’s disease. Dis Colon Rectum 29:495CrossRefGoogle Scholar
  10. Cirocco WC, Reilly JC, Rusin LC (1995) Life threatening hemorrhage and exsanguination from Crohn’s disease. Report of four cases. Dis Colon Rectum 38:85–95PubMedCrossRefGoogle Scholar
  11. Crohn BB, Ginzburg L, Oppenheimer GD (1932) Regional ileitis. JAMA 99:1323–1329CrossRefGoogle Scholar
  12. Ekelund GR, Lindhagen T (1989) Controversies in the surgical management of Crohn’s disease. Perspect Colon Rectal Surg 2:1–18Google Scholar
  13. Ewe K, Herfarth C, Malchow H et al. (1989) Postoperative recurrence of Crohn’s disease in relation to radicality of operation and sulfasalazine prophylaxis: A multicenter trial. Digestion 42:224–232PubMedCrossRefGoogle Scholar
  14. Farmer RG, Hawk WA, Turnbull RB (1975) Clinical patterns in Crohn’s disease: A statistical study of 615 cases. Gastroenterology 68:627–635PubMedGoogle Scholar
  15. Farmer RG, Michener WM, Mortimer EY (1980). Studies of family history among patients with inflammatory bowel disease. Clin Gastroenterology 9:271–278Google Scholar
  16. Garland CF, Lilienfeld AM, Mendeloff AI et al. (1981) Incidence rates of ulcerative colitis and Crohn’s disease in fifteen areas of the United States. Gastroenterology 81:1115–1124PubMedGoogle Scholar
  17. Gollop JH, Phillips SF, Melton LJ III et al. (1988) Epidemiologic aspects of Crohn’s disease: A population based study in Olmsted County, Minnesota, 1943–1982. Gut 29:49–56PubMedCrossRefGoogle Scholar
  18. Gordon PH, Nivatvongs S (1999) Principles and practice of surgery for the colon, rectum and anus, 2nd ed. QMP, St. Louis, USAGoogle Scholar
  19. Green EP, Tizard MLV, Moss MT, Thompson J, Winterbourne DJ, Mc Fadden JJ, Hermon-Taylor J (1989) Sequence and characteristics of IS-900, an insertion element identified in a human Crohn’s disease isolate of Mycobacterium paratuber-culosis. Nucleic Acid Res 17:9063–9073PubMedCrossRefGoogle Scholar
  20. Greenstein AJ (1987) The surgery of Crohn’s disease. Surg Clin N Am 67:573–596PubMedGoogle Scholar
  21. Greenstein AJ, Mann D, Sachar DB et al. (1985) Free perforation in Crohn’s disease. I. A survey of 99 cases. Am J Gastroenterol 80:682–689PubMedGoogle Scholar
  22. Griffiths AM, Ohlsson A, Sherman PM et al. (1995) Meta-analysis of enteral nutrition as a primary treatment of active Crohn’s disease. Gastroenterology 108:1056–1067PubMedCrossRefGoogle Scholar
  23. Gui G, Thomas P, Tizard M, Lake J, Sanderson JD, Hermon-Taylor J (1997) Two years outcome analysis of Crohn’s disease treated with rifabutin and macrolide antibiotics. J Anti-microb Chemother 39:393–400CrossRefGoogle Scholar
  24. Hanauer SB, Meyers S (1997) Management of Crohn’s disease in adults. Am J Gastroenterol 92:559–566PubMedGoogle Scholar
  25. Hansmann HJ, Kosa R, Düx M, Brado M, Goeser T, Roeren T, Stremmel W, Kauffmann GW (1997) Hydro-MRT chronisch entzündlicher Darmerkrankungen. Fortschr Roentgenstr 167:132–138CrossRefGoogle Scholar
  26. Haslam N, Hearing SD, Probert CS (2000) Audit of cyclosporin use in inflammatory bowel disease: Limited benefits, numerous side effects. Eur J Gastroenterol Hepatol 12:657–660Google Scholar
  27. Haug K, Schrumpf E, Halvorsen JF et al. (1989) Epidemiology of Crohn’s disease in Western Norway. Scand J Gastroenterol 24:1271–1275PubMedCrossRefGoogle Scholar
  28. Hermon-Taylor J (1998) The causation of Crohn’s disease and treatment with antimicrobial drugs. Ital J Gastroenterol Hepatol 30:607–610PubMedGoogle Scholar
  29. Herzog L, Herzog A, Glaser F, Herfarth C (1998) Rektovaginale Fisteln bei Patienten mit M. Crohn: Therapie und Prognose. Langenbecks Arch Chir Suppl. II:1002–1003Google Scholar
  30. Hulten L (1988) Surgical treatment of Crohn’s disease of the small bowel or ileocecum. Wordl J Surg 12:180–185CrossRefGoogle Scholar
  31. Ilnyckyj A, Greenberg H, Bernstein CN (1997) Escherichia coli 0157:H7 infection mimicking Crohn’s disease. Gastroenterology 112:995–999PubMedCrossRefGoogle Scholar
  32. Irvine EJ (1999) Development and subsequent refinement of the inflammatory bowel disease questionaire: A qualitiy of life instrument for adult patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 28:23–27CrossRefGoogle Scholar
  33. Katschinski B, Fingerle D, Scherbaum B et al. (1993) Oral contraceptives and cigarette smoking in Crohn’s disease. Dig Dis Sci 38:1596–1600PubMedCrossRefGoogle Scholar
  34. Li DJ, Freeman A, Miles KA et al. (1994) Can 99tcm HMPAO leucocyte scintigraphy distinguish betwen Crohn’s disease and ulceratice colitis? Br J Radiol 67:472–477PubMedCrossRefGoogle Scholar
  35. Lingren A, Wallerstedt S, Olsson R (1996) Prevalence of Crohn’s disease and simultaneous occurence of extraintestinal complications and cancer. An epidemiologic study in adults. Scand J Gastroenterol 31:74–78CrossRefGoogle Scholar
  36. Lochs H, Egger-Schoedl M, Schuh R, Meryn S, Westphal G, Poetze R (1984) Is tube feeding with elemental diets a primary therapy of Crohn’s disease ? Klin Wochenschr 62:821–825PubMedCrossRefGoogle Scholar
  37. Lockhardt-Mummery HE, Morson BC (1963) Crohn’s diseaseGoogle Scholar
  38. (regional enteritis) of the large intestine and its distinction from ulcerative colitis. Gut 1:87–105Google Scholar
  39. Malchow H, Ewe K, Brandes JW, Goebell H, Ehms H, Sommer H, Jesdinsky H (1984) European cooperative Crohn’s disease study (ECCDS). Results of drug treatment. Gastroenterology 84:249Google Scholar
  40. Manousos ON, Koutroubakis I, Potamianos S et al. (1996) A prosepctive epidemiologic study of Crohn’s disease in Her-aklion, Crete. Incidence over a 5 year period. Scand J Gastroenterol 31:599–603PubMedCrossRefGoogle Scholar
  41. Maté-Jimenez J, Munoz S, Vicent D et al. (1994) Incidence and prevalence of ulcerative colitis and Crohn’s disease in urban and rural areas of Spain from 1981–1988. J Clin Gastroenterol 18:27–31PubMedCrossRefGoogle Scholar
  42. Mayberry JF (1989) Recent epidemiology of ulcerative colitis and Crohn’s disease. Int J Colorectal Dis 4:59–66PubMedCrossRefGoogle Scholar
  43. McNamara MJ, Fazio VW, Lavery IC et al. (1990) Surgical treatment of enterovesical fistulas in Crohn’s disease. Dis Colon Rectum 33:271–276PubMedCrossRefGoogle Scholar
  44. Messori A, Brignola C, Trallori G et al. (1994) Effectiveness of 5-aminosalycilic acid for maintaining remission in patients with Crohn’s disease: A metanalysis. Am J Gastroenterol 89:692–698PubMedGoogle Scholar
  45. Mourn B, Vatn MH, Ekbom A et al. (1996) Incidence of Crohn’s disease in four countries in southeastern Norway, 1990–1993. A population-based study. Scand J Gastroenterol 31:355–361CrossRefGoogle Scholar
  46. Mowatt JI, Burnstein MJ (1993) Free perforation of small bowel Crohn’s disease: A case report and review. Can J Gastroenterol 7:300–302Google Scholar
  47. Nelson RL (1990) New medications for inflammatory bowel disease. Semin Colon Rectal Surg 3:168–175Google Scholar
  48. Odes HS, Locker C, Neumann L et al. (1994) Epidemiology of Crohn’s disease in Southern Israel. Am J Gastroenterol 89:1859–1862PubMedGoogle Scholar
  49. Papaioannau N, Piris J, Lee ECG et al. (1979) The relationship between histological inflammation in the cut ends after resection of Crohn’s disease and recurrence. Gut 20:A916Google Scholar
  50. Parks AG, Gordon PH, Hardcastle JE (1976) A classification of fistula in ano. Br J Surg 63:1–12PubMedCrossRefGoogle Scholar
  51. Pearson DC, May GR, Fick GH et al. (1995) Azathioprine and 6-mercaptopurine in Crohn’s disease. A metaanalysis. Am Int Med 122:132–142CrossRefGoogle Scholar
  52. Platell C, Mackay J, Collopy B et al. (1990) Anal pathology in patients with Crohn’s disease. Aust N Z J Surg 66:5–9CrossRefGoogle Scholar
  53. Post S, Herfarth C, Böhm E, Timmermanns G, Schumacher H, Schürmann G, Golling M (1996) The impact of diseases pattern, surgical management, and individual surgeons on the risk for relaparotomy for recurrent Crohn’s disease. Ann Surg 223:253–260PubMedCrossRefGoogle Scholar
  54. Prantera C, Zannoni F, Schribano ML et al. (1996) An antibiotic regiment for the treatment of active Crohn’s disease: A randomized, controlled trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 91:328–332PubMedGoogle Scholar
  55. Present DH (1999) The efficacy of infliximab in Crohn’s disease: Healing of fistulae. Aliment Pharmacol Ther 13 [Suppl 4]:23–28PubMedCrossRefGoogle Scholar
  56. Present DH, Korelitz BI, Wisch N et al. (1980) Treatment of Crohn’s disease with 6-Mercaptopurine. A longterm, randomized doubleblind study. N Engl J Med 302:981–987PubMedCrossRefGoogle Scholar
  57. Probert CSJ, Jayanthi V, Hughes AO et al. (1993) Prevalence and family risk of ulcerative colitis and Crohn’s disease: An epidemiologic study among Europeans and south asians in Leicestershire. Gut 34: 1547–1551PubMedCrossRefGoogle Scholar
  58. Reissman P, Salky BD, Edye M et al. (1996) Laparoscopic surgery in Crohn’s disease. Surg Endoscopy 10:1201–1204CrossRefGoogle Scholar
  59. Ritchie JK (1990) The results of Surgery for large bowel Crohn’s disease. Ann R Coll Surg Engl 72:155–157PubMedGoogle Scholar
  60. Russel MGVM, Stockbrügger RW (1996) Epidemiology of inflammatory bowel disease: An update. Scand J Gastroenterol 31:417–427PubMedCrossRefGoogle Scholar
  61. Salomon P, Kornbluth A, Aisenberg J et al. (1992) How effective are current drugs for Crohn’s disease? A meta-analysis. J Clin Gastroenterol 14:212–215CrossRefGoogle Scholar
  62. Sandborn WJ, Tremaine Wj, Lawson GM (1996) Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn’s disease treated with high-dose oral cyclosporine. Am J Gastroenterol 91:37–43PubMedGoogle Scholar
  63. Sanderson JD, Moss MT, Tizard MLV, Harmon-Taylor J (1992) Mycobacterium paratuberculosis DNA in Crohn’s disease tissue. Gut 33:890–896PubMedCrossRefGoogle Scholar
  64. Sartor RB (1995) Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn’s disease. Gastroenterol Clin North Am 24:475–507PubMedGoogle Scholar
  65. Sartor RB (1995) Current theories in the etiology of Crohn’s disease. Mt Sinai Newsletter 2:2–6Google Scholar
  66. Savoca PE, Ballantyne GH, Cahow CE (1990) Gastrointestinal malignancies in Crohn’s disease. A 20-year experience. Dis Colon Rectum 33:7–11PubMedCrossRefGoogle Scholar
  67. Scott NA, Hughes LE (1994) Timing of ileocolonic resection for symptomatic Crohn’s disease — the patient’s view. Gut 35:656–657PubMedCrossRefGoogle Scholar
  68. Singer HC, Anderson JGD, Frischer H, Kirschner JB (1971) Familial aspects of inflammatory bowel disease. Gastroenterology 61:423–430PubMedGoogle Scholar
  69. Singleton JW, Hanauer SB, Gitnick GL et al. (1993) Mesalamine capsules for the treatment of active Crohn’s disease: Result of a 16 week trial. Gastroenterology 104:1293–1301PubMedGoogle Scholar
  70. Softley A, Clamp SE, Bouchier IAD et al. (1988) Perforation of the intestine in inflammatory bowel disease. An OMGE survey. Scand J Gastroenterol 23 [Suppl 144]:24–26Google Scholar
  71. Speranza V, Zimi M, Leardi S et al. (1986) Recurrence of Crohn’s disease. Are there any risk factors ? J Clin Gastroenterol 8:640PubMedCrossRefGoogle Scholar
  72. Stange EF, Schreiber S, Raedler A, Stallmach A, Schölmerich J, Loeschke K, Starlinger M, Fischbach W, Caspary WF (1997) Therapie des M. Crohn — Ergebnisse einer Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten. Z Gastroenterol 35:541–554PubMedGoogle Scholar
  73. Stokes MA (1992) Crohn’s disease and nutrition. Br J Surg 79:391–394PubMedCrossRefGoogle Scholar
  74. Stowe SP, Redmond SR, Stormont JM et al. (1990) An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology 98:104–110PubMedGoogle Scholar
  75. Summers RW, Switz DM, Session JT, Becktel JM, Best WR, Kern F Jr, Singleton JW (1979) National cooperative Crohn’s disease study. Results of drug treatment. Gastroenterology 77:847PubMedGoogle Scholar
  76. Targan SP, Hanauer SB, van Deventer SJ et al. (1997) A short term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. N Engl J Med 337:1029–1035PubMedCrossRefGoogle Scholar
  77. Tragnone A, Corrao G, Miglio F et al. (1996) Incidence of inflammatory bowel disease in Italy: A nationwide population-based study.Google Scholar
  78. Tsianos EV, Masalas CN, Merkouropoulos M et al. (1994) Incidence of inflammatory bowel disease in northwest Greece: Rarity of Crohn’s disease in an area where ulcerative colitis is common. Gut 35:369–372PubMedCrossRefGoogle Scholar
  79. Wakefield AJ, Ekbom A, Dhillon AP et al. (1995) Crohn’s disease: pathogenesis and persistent measles virus infection. 108:911–916Google Scholar
  80. Zang L, Anderson FH (1996) Seasonal change in exacerbation of Crohn’s disease. Scand J Gastroenterol 31:79–82CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • J. Schmidt
  • C. Herfarth

There are no affiliations available

Personalised recommendations